This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Safety, Tolerability, Efficacy and QoL Study of ...
Clinical trial

A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI (ALPINE)

Read time: 1 mins
Last updated:27th Jun 2014

The purpose of this study is to determine whether recombinant Alkaline Phosphatase (recAP) is effective and save, and to determine the most effective dose, in the treatment of patients with acute kidney injury caused by sepsis.

Category Value
Study start date 2014-06-27

View full details